Resolved
Champix 1 mg tablets
varenicline tartrate · 1 mg tablet
Champix
- Reported
- 10 September 2024
- Expected resolution
- 31 January 2025
- TGA reference
- TGA-MSI-2024-043
- Sponsor
- Pfizer Australia Pty Ltd
Reason for shortage
Nitrosamine impurity investigation led to a precautionary recall. Pfizer resolved impurity issue and supply resumed February 2025.
What to do
- 1.Shortage is resolved — Supply has been restored. If you experienced disruption, speak with your pharmacist or prescriber about returning to your usual medicine if you were switched to an alternative.
Suggested alternatives
Same or related therapeutic class. Always discuss with your doctor or pharmacist before switching.
- Nicotine replacement therapy — patches, gum, lozenges
- Bupropion (Wellbutrin XL) 300 mg — second-line smoking cessation
Official resources
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.